Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000935836-20-000390
Filing Date
2020-07-20
Accepted
2020-07-20 16:34:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 glyco13g.htm SC 13G 45342
  Complete submission text file 0000935836-20-000390.txt   46778
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Subject) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87811 | Film No.: 201036712
SIC: 2834 Pharmaceutical Preparations

Mailing Address 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103 415-448-6534
EcoR1 Capital, LLC (Filed by) CIK: 0001587114 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G